WIRB-Copernicus Group Acquires Vigilare International

November 28, 2017

Applied Clinical Trials

WIRB Copernicus Group® announced its acquirement of Vigilare International, a provider of integrated, end-to-end pharmacovigilance and drug safety solutions for the biopharmaceutical and biotech industry. This new acquistion is a perfect fit for both companies as Vigilare compliments WCG's existing clinical research solutions and they plan to identify more opportunities to streamline clinical research operations.

Read the full release here.

Related Content: